Showing 1–6 of 6 results for author: Saboury, B

Nuclear Medicine Artificial Intelligence in Action: The Bethesda Report (AI Summit 2024)

Authors: Arman Rahmim, Tyler J. Bradshaw, Guido Davidzon, Joyita Dutta, Georges El Fakhri, Munir Ghesani, Nicolas A. Karakatsanis, Quanzheng Li, Chi Liu, Emilie Roncali, Babak Saboury, Tahir Yusufaly, Abhinav K. Jha

Abstract: The 2nd SNMMI Artificial Intelligence (AI) Summit, organized by the SNMMI AI Task Force, took place in Bethesda, MD, on February 29 - March 1, 2024. Bringing together various community members and stakeholders, and following up on a prior successful 2022 AI Summit, the summit theme was: AI in Action. Six key topics included (i) an overview of prior and ongoing efforts by the AI task force, (ii) em… ▽ More The 2nd SNMMI Artificial Intelligence (AI) Summit, organized by the SNMMI AI Task Force, took place in Bethesda, MD, on February 29 - March 1, 2024. Bringing together various community members and stakeholders, and following up on a prior successful 2022 AI Summit, the summit theme was: AI in Action. Six key topics included (i) an overview of prior and ongoing efforts by the AI task force, (ii) emerging needs and tools for computational nuclear oncology, (iii) new frontiers in large language and generative models, (iv) defining the value proposition for the use of AI in nuclear medicine, (v) open science including efforts for data and model repositories, and (vi) issues of reimbursement and funding. The primary efforts, findings, challenges, and next steps are summarized in this manuscript. △ Less

Submitted 3 June, 2024; originally announced June 2024.

Issues and Challenges in Applications of Artificial Intelligence to Nuclear Medicine -- The Bethesda Report (AI Summit 2022)

Authors: Arman Rahmim, Tyler J. Bradshaw, Irène Buvat, Joyita Dutta, Abhinav K. Jha, Paul E. Kinahan, Quanzheng Li, Chi Liu, Melissa D. McCradden, Babak Saboury, Eliot Siegel, John J. Sunderland, Richard L. Wahl

Abstract: The SNMMI Artificial Intelligence (SNMMI-AI) Summit, organized by the SNMMI AI Task Force, took place in Bethesda, MD on March 21-22, 2022. It brought together various community members and stakeholders from academia, healthcare, industry, patient representatives, and government (NIH, FDA), and considered various key themes to envision and facilitate a bright future for routine, trustworthy use of… ▽ More The SNMMI Artificial Intelligence (SNMMI-AI) Summit, organized by the SNMMI AI Task Force, took place in Bethesda, MD on March 21-22, 2022. It brought together various community members and stakeholders from academia, healthcare, industry, patient representatives, and government (NIH, FDA), and considered various key themes to envision and facilitate a bright future for routine, trustworthy use of AI in nuclear medicine. In what follows, essential issues, challenges, controversies and findings emphasized in the meeting are summarized. △ Less

Submitted 7 November, 2022; originally announced November 2022.

AI-Based Detection, Classification and Prediction/Prognosis in Medical Imaging: Towards Radiophenomics

Authors: Fereshteh Yousefirizi, Pierre Decazes, Amine Amyar, Su Ruan, Babak Saboury, Arman Rahmim

Abstract: Artificial intelligence (AI) techniques have significant potential to enable effective, robust and automated image phenoty** including identification of subtle patterns. AI-based detection searches the image space to find the regions of interest based on patterns and features. There is a spectrum of tumor histologies from benign to malignant that can be identified by AI-based classification appr… ▽ More Artificial intelligence (AI) techniques have significant potential to enable effective, robust and automated image phenoty** including identification of subtle patterns. AI-based detection searches the image space to find the regions of interest based on patterns and features. There is a spectrum of tumor histologies from benign to malignant that can be identified by AI-based classification approaches using image features. The extraction of minable information from images gives way to the field of radiomics and can be explored via explicit (handcrafted/engineered) and deep radiomics frameworks. Radiomics analysis has the potential to be utilized as a noninvasive technique for the accurate characterization of tumors to improve diagnosis and treatment monitoring. This work reviews AI-based techniques, with a special focus on oncological PET and PET/CT imaging, for different detection, classification, and prediction/prognosis tasks. We also discuss needed efforts to enable the translation of AI techniques to routine clinical workflows, and potential improvements and complementary techniques such as the use of natural language processing on electronic health records and neuro-symbolic AI techniques. △ Less

Submitted 13 January, 2022; v1 submitted 19 October, 2021; originally announced October 2021.

Role of AI in Theranostics: Towards Routine Personalized Radiopharmaceutical Therapies

Authors: Julia Brosch-Lenz, Fereshteh Yousefirizi, Katherine Zukotynski, Jean-Mathieu Beauregard, Vincent Gaudet, Babak Saboury, Arman Rahmim, Carlos Uribe

Abstract: We highlight emerging uses of artificial intelligence (AI) in the field of theranostics, focusing on its significant potential to enable routine and reliable personalization of radiopharmaceutical therapies (RPTs). Personalized RPTs require patient-individual dosimetry calculations accompanying therapy. Image-based dosimetry needs: 1) quantitative imaging; 2) co-registration and organ/tumor identi… ▽ More We highlight emerging uses of artificial intelligence (AI) in the field of theranostics, focusing on its significant potential to enable routine and reliable personalization of radiopharmaceutical therapies (RPTs). Personalized RPTs require patient-individual dosimetry calculations accompanying therapy. Image-based dosimetry needs: 1) quantitative imaging; 2) co-registration and organ/tumor identification on serial and multimodality images; 3) determination of the time-integrated activity; and 4) absorbed dose determination. AI models that facilitate these steps are reviewed. Additionally we discuss the potential to exploit biological information from diagnostic and therapeutic molecular images to derive biomarkers for absorbed dose and outcome prediction, towards personalization of therapies. We try to motivate the nuclear medicine community to expand and align efforts into making routine and reliable personalization of RPTs a reality. △ Less

Submitted 31 July, 2021; v1 submitted 29 July, 2021; originally announced July 2021.

Comments: 30 pages, 6 figures, 1 table

Toward High-Throughput Artificial Intelligence-Based Segmentation in Oncological PET Imaging

Authors: Fereshteh Yousefirizi, Abhinav K. Jha, Julia Brosch-Lenz, Babak Saboury, Arman Rahmim

Abstract: Artificial intelligence (AI) techniques for image-based segmentation have garnered much attention in recent years. Convolutional neural networks (CNNs) have shown impressive results and potential towards fully automated segmentation in medical imaging, and particularly PET imaging. To cope with the limited access to annotated data needed in supervised AI methods, given tedious and prone-to-error m… ▽ More Artificial intelligence (AI) techniques for image-based segmentation have garnered much attention in recent years. Convolutional neural networks (CNNs) have shown impressive results and potential towards fully automated segmentation in medical imaging, and particularly PET imaging. To cope with the limited access to annotated data needed in supervised AI methods, given tedious and prone-to-error manual delineations, semi-supervised and unsupervised AI techniques have also been explored for segmentation of tumors or normal organs in single and bi-modality scans. This work provides a review of existing AI techniques for segmentation tasks and the evaluation criteria for translational AI-based segmentation efforts towards routine adoption in clinical workflows. △ Less

Submitted 15 November, 2021; v1 submitted 28 July, 2021; originally announced July 2021.

Comments: This manuscript has been accepted for publication in PET Clinics, Volume 16, Issue 4, 2021

Journal ref: PET Clinics, Volume 16, Issue 4, 2021

Objective task-based evaluation of artificial intelligence-based medical imaging methods: Framework, strategies and role of the physician

Authors: Abhinav K. Jha, Kyle J. Myers, Nancy A. Obuchowski, Zi** Liu, Md Ashequr Rahman, Babak Saboury, Arman Rahmim, Barry A. Siegel

Abstract: Artificial intelligence (AI)-based methods are showing promise in multiple medical-imaging applications. Thus, there is substantial interest in clinical translation of these methods, requiring in turn, that they be evaluated rigorously. In this paper, our goal is to lay out a framework for objective task-based evaluation of AI methods. We will also provide a list of tools available in the literatu… ▽ More Artificial intelligence (AI)-based methods are showing promise in multiple medical-imaging applications. Thus, there is substantial interest in clinical translation of these methods, requiring in turn, that they be evaluated rigorously. In this paper, our goal is to lay out a framework for objective task-based evaluation of AI methods. We will also provide a list of tools available in the literature to conduct this evaluation. Further, we outline the important role of physicians in conducting these evaluation studies. The examples in this paper will be proposed in the context of PET with a focus on neural-network-based methods. However, the framework is also applicable to evaluate other medical-imaging modalities and other types of AI methods. △ Less

Submitted 20 July, 2021; v1 submitted 9 July, 2021; originally announced July 2021.